DOCTOR AFTER HOURS GOLD COAST

To arrange an After Hours Doctor

55 311 224

INTERESTING MEDICAL NEWS

NASDAQ announces delisting of deCODE genetics common stock -
Hundreds of thousands of Idahoans struggling with the high cost of health care received bad news last night -- no relief and more problems are on the way. With the passage of the Idaho Health Freedom Act (House Bill 391), the Senate moved forward legislation that could spell disaster for Idaho's health care system, while addressing none of the health care issues plaguing families across the state.

Mayo Clinic to form new permanent professorship for cancer research -
The Associated Press/The Washington Times: Sen. Blanche Lincoln, D-Ark., "insisted Tuesday she remained opposed to pushing a health care bill through the Senate with a simple majority vote, despite saying she wanted to see what was in the legislation." Lincoln "said those comments didn't represent a change of heart on her stance against the controversial majority-vote procedure known as 'reconciliation.' 'I don't support reconciliation. All I said was I want to see what's in it,' Lincoln told reporters outside the Senate floor. She walked quickly into a senators-only area without elaborating" (Werner, 3/9).

Liberator Medical Holdings closes private placement of 4.66M common stock shares -
Shahriar Koochekpour, MD, PhD, Assistant Professor of Microbiology and Immunology, Biochemistry and Molecular Biology, and Genetics at LSU Health Sciences Center New Orleans, led research that has discovered, for the first time, a genetic mutation in African-American men with a family history of prostate cancer who are at increased risk for the disease.

Kinetic Concepts wins patent infringement case -
Breast cancer continues to rise in Iraq, and scientists have established the Iraqi National Cancer Research Program to better understand the underlying molecular and environmental causes in an effort to curb the incidence of cancer.

Medical Alarm Concepts Holding's MediPendant device with DECT technology receives FCC approval -
A thyroid-hormone-like substance that works specifically on the liver reduces blood cholesterol with no serious side effects. This according to a clinical trial conducted by researchers from the Swedish medical university Karolinska Institutet, amongst other centres, published today in the top-ranking scientific periodical The New England Journal of Medicine.